259 related articles for article (PubMed ID: 38544689)
1. The emerging role and clinical significance of circRNAs in papillary thyroid cancer.
Ma J; Xu J; Zhang X; Quan J
Front Endocrinol (Lausanne); 2024; 15():1351776. PubMed ID: 38544689
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Roles of circRNAs in Papillary Thyroid Carcinoma: Molecular Mechanisms and Biomarker Potential.
Ye H; Sun X; Ding Q; Yang E; Zhao S; Fan X; Fang M; Ding X
Protein Pept Lett; 2023; 30(9):709-718. PubMed ID: 37537939
[TBL] [Abstract][Full Text] [Related]
3. Advances on circRNAs Contribute to Carcinogenesis and Progression in Papillary Thyroid Carcinoma.
Xu X; Jing J
Front Endocrinol (Lausanne); 2020; 11():555243. PubMed ID: 33551989
[TBL] [Abstract][Full Text] [Related]
4. The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases.
Zhang Y; Jia DD; Zhang YF; Cheng MD; Zhu WX; Li PF; Zhang YF
Int J Biol Sci; 2021; 17(7):1731-1741. PubMed ID: 33994857
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma.
Guo M; Sun Y; Ding J; Li Y; Yang S; Zhao Y; Jin X; Li SS
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165176
[TBL] [Abstract][Full Text] [Related]
6. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
7. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
9. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
Zheng H; Fu Q; Ma K; Shi S; Fu Y
Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA expression and association with the clinicopathological characteristics in papillary thyroid carcinoma.
Guo D; Li F; Zhao X; Long B; Zhang S; Wang A; Cao D; Sun J; Li B
Oncol Rep; 2020 Aug; 44(2):519-532. PubMed ID: 32468074
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
Lan X; Cao J; Xu J; Chen C; Zheng C; Wang J; Zhu X; Zhu X; Ge M
J Clin Lab Anal; 2018 Oct; 32(8):e22573. PubMed ID: 29790216
[TBL] [Abstract][Full Text] [Related]
14. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
[TBL] [Abstract][Full Text] [Related]
15. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer.
Dai L; Hu W; Jiang H; Wang Y; Le Q; Wu X; Meng X
Int J Clin Oncol; 2023 Nov; 28(11):1461-1474. PubMed ID: 37568034
[TBL] [Abstract][Full Text] [Related]
17. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
[TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
Yao Y; Chen X; Yang H; Chen W; Qian Y; Yan Z; Liao T; Yao W; Wu W; Yu T; Chen Y; Zhang Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):318. PubMed ID: 31324198
[TBL] [Abstract][Full Text] [Related]
20. Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.
Ye J; Feng JW; Wu WX; Qi GF; Wang F; Hu J; Hong LZ; Liu SY; Jiang Y
J Endocrinol Invest; 2023 Mar; 46(3):509-522. PubMed ID: 36115894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
